Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in EnglandScott Goulden, Kiera Heffernan, Fulya Sen Nikitas, Urmi Shukla, Craig Knott, Matthias Hunger, Ankit Pahwa, Rene Schade
24 August 2023
Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune frameworkValentina Bruno, Martina Betti, Lorenzo D’Ambrosio, Alice Massacci, Benito Chiofalo, Adalgisa Pietropolli, Giulia Piaggio, Gennaro Ciliberto, Paola Nisticò, Matteo Pallocca, Alessandro Buda, Enrico Vizza
24 October 2023
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutionsThomas J Herzog, Shaun A Wahab, Mansoor R Mirza, Bhavana Pothuri, Ignace Vergote, Whitney S Graybill, Izabela A Malinowska, Whitney York, Jean A Hurteau, Divya Gupta, Antonio González-Martin, Bradley J Monk
6 November 2023
Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancerFranziska Siegenthaler, Elisabeth Epstein, Carol A Büchi, Andrea Gmür, Flurina A C M Saner, Tilman T Rau, Joseph W Carlson, Michael D Mueller, Sara Imboden
4 September 2023
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumorsUlrika Joneborg, Alice Bergamini, Emelie Wallin, Giorgia Mangili, Olesya Solheim, Gloria Marquina, Antonio Casado, Erik Rokkones, John Coulter, Christianne A R Lok, Nienke van Trommel, Frédéric Amant, Pierre-Adrien Bolze, Jalid Sehouli, Sileny HanSee the full list of authors
2 October 2023
Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature reviewDana M Chase, Anadi Mahajan, David Alexander Scott, Neil Hawkins, Linda Kalilani
29 August 2023
Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancerFlurina Anna-Carina Maria Saner, Giovanni Ruggeri, Franziska Siegenthaler, Julian Wampfler, Sara Imboden, Michael D Mueller
10 August 2023
Intracystic endometrioid borderline tumorHoussein El Hajj, Fabrice Narducci, Glenn McCluggage, Camille Pasquesoone
5 August 2023
Correspondence on 'Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy' by Capozzi et alAlessandro Buda, Mauro Signorelli, Andrea Papadia
4 September 2023
Exploring international differences in ovarian cancer care: a survey report on global patterns of care, current practices, and barriersMarc Daniël Algera, Rhett Morton, Sudha S Sundar, Rhonda Farrell, Willemien J van Driel, Donal Brennan, Marcus J Rijken, Selina Sfeir, Lucy Allen, Mary Eiken, Robert L Coleman, , the collaborators of the Global Equality in Ovarian Cancer Care project group, A Alvarez Secord, G BaiocchiSee the full list of authors
17 August 2023